Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases

QR Code

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases

Currently, natriuretic peptides (including brain natriuretic peptide (BNP)) are widely used in clinical practice as biomarkers for various cardiovascular diseases. Study of the structure and function of NPPA-NPPB locus can help to better identify patients at risk of future cardiovascular diseases, i...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. Ya. Panarina, G. I. Lifshits
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2024-11-01
Series:	Российский кардиологический журнал
Subjects:	genetic polymorphisms natriuretic peptide brain natriuretic peptide n-terminal pro-brain natriuretic peptide genetic markers
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/5906
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Point-of-care N-terminal pro-brain natriuretic peptide testing in patients with heart failure: data from the DREAM study
by: F. I. Belyalov, et al.
Published: (2024-06-01)

The level of Brain natriuretic Peptide as a Predictor of the Postoperative Period at Operations with Artificial Blood circulation
by: Yu. A. Bakhareva, et al.
Published: (2019-01-01)

Efficiency of meldonium application in complex treatment of patients with chronic heart failure decompensation
by: A. S. Sycheva, et al.
Published: (2021-06-01)

GENDER AND AGE DIFFERENCES OF BRAIN NATRIURETIC PEPTIDE CONCENTRATION IN PATIENTS WITH MYOCARDIAL INFARCTION
by: E. N. Usoltseva, et al.
Published: (2014-07-01)

NEW POSSIBILITIES FOR EVALUATION OF SEVERITY AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE BASED ON N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE PLASMA LEVEL
by: A. S. Galjavich, et al.
Published: (2016-01-01)

Brain natriuretic peptide and all-cause mortality in patients treated with haemodialysis
by: Maria K Svensson, et al.
Published: (2025-06-01)

Modification of the Association of B-Type Natriuretic Peptides With Mortality and Hospitalization Outcomes by Sex
by: David Bobrowski, MD, et al.
Published: (2025-08-01)

The level of N-terminal pro-brain natriuretic peptide depending on vascular wall condition and bone mass in postmenopausal women
by: I. A. Skripnikova, et al.
Published: (2020-07-01)

Role of brain natriuretic peptide in the pathogenesis of resistant hypertension
by: K. Yu. Nikolaev, et al.
Published: (2023-02-01)

Endothelium-derived C-type natriuretic peptide offsets the pathogenesis of pulmonary hypertension
by: Joshua P. Dignam, et al.
Published: (2025-09-01)

Assessment of glomerular and tubulointerstitial apparatus state depending on the level of the natriuretic peptide in hypertension patients
by: A. I. Chernyavina
Published: (2020-04-01)

The relationship of gene polymorphism with the heart failure risk in patients with hypertension and high adherence to treatment
by: N. A. Koziolova, et al.
Published: (2020-04-01)

NATRIURETIC PEPTIDE AND HIS PROGENITORS AS PREDICTORS OF PROGRESSIVE POSTOPERATIVE LEFT VENTRICLE REMODELING IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
by: S. S. Gutor, et al.
Published: (2013-12-01)

INTEGRATION OF BIOMARKERS INTO THE PRACTICE OF TREATING PATIENTS WITH HEART FAILURE: THE ROLE OF DETERMINING THE BLOOD LEVEL OF NATRIURETIC PEPTIDES
by: S. R. Gilyarevskiy, et al.
Published: (2017-12-01)

EFFECTIVENESS OF PHARMACOTHERAPY FOR NORMALIZATION OF THE BRAIN NATRIURETIC PEPTIDE, RENINE-ANGIOTENSINALDOSTERONE SYSTEM ACTIVATION AFTER SURGICAL REVASCULARIZATION OF MYOCARDIUM IN POSTINFARCTION CARDIOSCLEROSIS PATIENTS
by: S. A. Kovalev, et al.
Published: (2016-12-01)

B-type natriuretic peptide informativeness in myocardial revascularization with cardio-pulmonary bypass
by: I. A. Kozlov, et al.
Published: (2024-08-01)

Predictive value of brain natriuretic peptide for cardiovascular risk assessment in non-cardiac surgery
by: O. N. Dzhioeva, et al.
Published: (2020-11-01)

Associations of elevated levels of brain natriuretic peptide and heart failure and their contribution to survival in the Russian middle-aged population: data from the ESSE-RF study
by: S. A. Shalnova, et al.
Published: (2023-07-01)

N-terminal pro-brain natriuretic peptide in essential arterial hypertension patients: antihypertensive therapy effects
by: A. S. Galyavich, et al.
Published: (2006-10-01)

Natriuretic peptides and chronic heart failure in arterial hypertension patients
by: Yu. A. Vasuyk, et al.
Published: (2007-04-01)

BRAIN NATRIURETIC PEPTIDE AS BIOCHEMICAL MARKER FOR STRUCTURAL AND FUNCTIONAL HEART DISORDERS IN ARTERIAL HYPERTENSION
by: S. V. Ivanova, et al.
Published: (2015-12-01)

Evaluation N-terminal pro-B-type natriuretic peptide and other biochemical parameters in heart failure with or without chronic kidney disease in Kirkuk city
by: Firas Tariq, et al.
Published: (2024-10-01)

CLINICAL SIGNIFICANCE OF N-TERMINAL FRAGMENT OF NATRIURETIC PEPTIDE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO DO NOT RECEIVE PATHOGENETIC THERAPY
by: T. A. Panafidina, et al.
Published: (2017-09-01)

ECHOCARDIOGRAPHIC AND LABORATORY MARKERS OF CHRONIC HEART FAILURE: WHETHER IT IS POSSIBLE TO USE THEM IN RHEUMATIC MITRAL DISEASES?
by: T. A. Kazakovtseva, et al.
Published: (2016-01-01)

Effects of Acute Exercise Bouts on Cardiovascular Biomarkers in Runners with Exercise-Induced Hypertension
by: Young-Joo Kim, et al.
Published: (2025-06-01)

N-terminal Pro-B-Type Natriuretic Peptide is a Myocardial Biomarker in Pulmonary Sepsis and Septic Shock
by: I. N. Tyurin, et al.
Published: (2022-10-01)

CENTRAL HEMODYNAMIC PARAMETERS IN PATIENTS WITH IDIOPATHIC ATRIAL FIBRILLATION
by: K. V. trakhova, et al.
Published: (2011-06-01)

Integral assessment of congestion in patients with acute decompensated heart failure
by: Zh. D. Kobalava, et al.
Published: (2022-03-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Natriuretic peptides: new challenges — new solutions
by: O. M. Drapkina, et al.
Published: (2021-11-01)

Impact of acute covid-19 on cardiac function in the long term: a systematic review
by: Luiz Humberto Marochi, et al.
Published: (2025-07-01)

Risk factors and diagnostic value of urinary N-terminal pro-brain natriuretic peptide for verification of heart failure in human immunodeficiency virus-infected patients
by: O. G. Goryacheva, et al.
Published: (2022-03-01)

Factors associated with long-term adverse cardiovascular events in patients with type 2 diabetes
by: A. A. Demin, et al.
Published: (2021-12-01)

TISSUE DOPPLEROGRAPHY IN EARLY DIAGNOSIS OF FUNCTIONAL MYOCARDIAL DISORDERS IN ARTERIAL HYPERTENSION
by: Y. A. Vasyuk, et al.
Published: (2016-01-01)

Risk factors and diagnostic significance of the N-terminal pro-brain natriuretic peptide as a marker in patients with acute decompensated heart failure and diabetic kidney disease
by: N. A. Koziolova, et al.
Published: (2021-04-01)

DIABETES MELLITUS 2ND TYPE WITH CARDIOVASCULAR AUTONOMIC NEUROPATHY
by: V. A. Serhiyenko, et al.
Published: (2015-09-01)

Evaluation of proinflammatory cytokines and brain natriuretic peptide in patients with rheumatic heart diseases and coronary heart disease complicated by chronic heart insufficiency
by: N A Shoslak, et al.
Published: (2005-04-01)

Biochemical factors in the blood serum of neuroendocrine tumor patients with carcinoid syndrome
by: N. V. Lyubimova, et al.
Published: (2022-12-01)

REMODELING OF THE RIGHT HEART AND THE LEVEL OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: A COMPARATIVE CROSS-SECTIONAL OBSERVATIONAL STUDY
by: A. A. Klimenko, et al.
Published: (2015-09-01)

Features of cardiovascular remodeling, the level of neurohumoral factors depending on the degree of chronic heart failure and kidney dysfunction
by: U. K. Kamilova, et al.
Published: (2019-06-01)